These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 16276218)
21. Low-dose vasopressin infusion can be an alternative in treating patients with refractory septic shock combined with chronic pulmonary hypertension--a case report. Wang HJ; Wong CS; Chiang CY; Yeh CC; Cherng CH; Ho ST; Wu CT Acta Anaesthesiol Sin; 2003 Jun; 41(2):77-80. PubMed ID: 12934421 [TBL] [Abstract][Full Text] [Related]
22. The role of vasopressin and the vasopressin type V1a receptor agonist selepressin in septic shock. Saad AF; Maybauer MO J Crit Care; 2017 Aug; 40():41-45. PubMed ID: 28319910 [TBL] [Abstract][Full Text] [Related]
23. Clinical review: Vasopressin and terlipressin in septic shock patients. Delmas A; Leone M; Rousseau S; Albanèse J; Martin C Crit Care; 2005 Apr; 9(2):212-22. PubMed ID: 15774080 [TBL] [Abstract][Full Text] [Related]
24. Does the Addition of Vasopressin to Catecholamine Vasopressors Affect Outcomes in Patients With Distributive Shock? Roumpf SK; Hunter BR Ann Emerg Med; 2019 Jul; 74(1):153-155. PubMed ID: 30446352 [No Abstract] [Full Text] [Related]
25. More than skin deep? Complications associated with vasopressin infusion: a cautionary tale. Mariscalco MM Crit Care Med; 2003 May; 31(5):1587-8. PubMed ID: 12771642 [No Abstract] [Full Text] [Related]
26. Combined use of high doses of vasopressin and corticosteroids in a patient with Crohn's disease with refractory septic shock after intestinal perforation: a case report. Notaro S; Sorrentino M; Ruocco A; Notaro A; Corcione A; Murino P; Piscitelli E; Tamborino M J Med Case Rep; 2017 Nov; 11(1):320. PubMed ID: 29129185 [TBL] [Abstract][Full Text] [Related]
27. Vasopressin in septic shock. Russell JA Crit Care Med; 2007 Sep; 35(9 Suppl):S609-15. PubMed ID: 17713417 [No Abstract] [Full Text] [Related]
28. Fontan operation, vasopressin and septic shock: a case report on the usual treatment in a peculiar setting. Vitale V; Ricci Z; Favia I; Fragasso T; Cogo P; Rossi E Pediatr Cardiol; 2011 Dec; 32(8):1273-4. PubMed ID: 21938541 [No Abstract] [Full Text] [Related]
29. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study. Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364 [TBL] [Abstract][Full Text] [Related]
30. The role of vasopressin in the management of sepsis. Roberts JC; Darwin LM; Washington S Br J Hosp Med (Lond); 2012 May; 73(5):298. PubMed ID: 22585336 [No Abstract] [Full Text] [Related]
31. Prospective Open-label Trial of Early Concomitant Vasopressin and Norepinephrine Therapy versus Initial Norepinephrine Monotherapy in Septic Shock. Hammond DA; Ficek OA; Painter JT; McCain K; Cullen J; Brotherton AL; Kakkera K; Chopra D; Meena N Pharmacotherapy; 2018 May; 38(5):531-538. PubMed ID: 29600824 [TBL] [Abstract][Full Text] [Related]
32. The long-term survival rate of catecholamine-resistant septic shock in Japanese patients who received vasopressin therapy. Sawa N; Ubara Y; Katori H; Hoshino J; Suwabe T; Takemoto F; Uchida N; Masuoka K; Wake A; Taniguchi S; Takaichi K Clin Nephrol; 2009 Aug; 72(2):129-36. PubMed ID: 19640370 [TBL] [Abstract][Full Text] [Related]
33. Exogenous Vasopressin-Induced Hyponatremia in Patients With Vasodilatory Shock: Two Case Reports and Literature Review. Salazar M; Hu BB; Vazquez J; Wintz RL; Varon J J Intensive Care Med; 2015 Jul; 30(5):253-8. PubMed ID: 24106070 [TBL] [Abstract][Full Text] [Related]
34. Does body weight impact the efficacy of vasopressin therapy in the management of septic shock? Miller JT; Welage LS; Kraft MD; Alaniz C J Crit Care; 2012 Jun; 27(3):289-93. PubMed ID: 21855282 [TBL] [Abstract][Full Text] [Related]
35. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock. Daley MJ; Lat I; Mieure KD; Jennings HR; Hall JB; Kress JP Ann Pharmacother; 2013 Mar; 47(3):301-10. PubMed ID: 23447481 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of Vasopressin for Septic Shock in Patients on Chronic Renin-Angiotensin-Aldosterone System Inhibitors. Erwin BL; Denaburg MA; Barker AB; McArdle PJ; Windham ST; Morgan CJ Crit Care Med; 2017 Dec; 45(12):e1226-e1232. PubMed ID: 28991825 [TBL] [Abstract][Full Text] [Related]
37. Dear vasopressin, where is your place in septic shock? Duenser MW; Hasibeder WR Crit Care; 2005 Apr; 9(2):134-5. PubMed ID: 15774061 [TBL] [Abstract][Full Text] [Related]
38. Safe Use of Vasopressin and Angiotensin II for Patients with Circulatory Shock. Bauer SR; Sacha GL; Lam SW Pharmacotherapy; 2018 Aug; 38(8):851-861. PubMed ID: 29878459 [TBL] [Abstract][Full Text] [Related]
39. Rationale and Design of an Adaptive Phase 2b/3 Clinical Trial of Selepressin for Adults in Septic Shock. Selepressin Evaluation Programme for Sepsis-induced Shock-Adaptive Clinical Trial. Lewis RJ; Angus DC; Laterre PF; Kjølbye AL; van der Meulen E; Blemings A; Graves T; Russell JA; Carlsen JE; Jacobsen K; Yealy DM; Opal SM; Windeløv NA; François B; Perner A; Pickkers P; Berry SM Ann Am Thorac Soc; 2018 Feb; 15(2):250-257. PubMed ID: 29388815 [TBL] [Abstract][Full Text] [Related]